We are live on ! Find out more
OSRHW

OSR Health Warrant
OSRHW

17 hedge funds and large institutions have $360K invested in OSR Health Warrant in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $336K → $360K (+$23.8K)

15% less funds holding

Funds holding: 2017 (-3)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
17
Holders Change
-3
Holders Change %
-15%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change

OSRHW Hedge Fund Activity: Q4 2025 in Review

17 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in OSR Health Warrant (OSRHW) for Q4 2025, worth a combined $360K — up 7.1% from $336K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of OSRHW and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Flow Traders U.S., adding an estimated $14. The largest seller was Susquehanna International Group, exiting entirely with an estimated $1.94K sold.

  • 17 institutional investors held OSR Health Warrant (OSRHW) as of Q4 2025, down from 20 in Q3 2025.
  • Funds reported $360K of OSR Health Warrant stock for Q4 2025, up 7.1% quarter-over-quarter.
  • 0 funds opened new OSR Health Warrant positions in Q4 2025 and 2 closed out, a net change of -2 holders.
  • The largest OSR Health Warrant buyer in Q4 2025 was Flow Traders U.S., an estimated $14 added.
  • The largest OSR Health Warrant seller in Q4 2025 was Susquehanna International Group, an estimated $1.94K sold.

Based on aggregated 13F filings for Q4 2025.